Take the exact medicine name to the plan
Would the plan pay for this particular medicine for the reason it is being proposed? That is the question to ask. Keep the product name and form in front of you while speaking with the plan. Ask about the visit itself in a separate question so the answers do not get mixed together.
A formulary names the drugs your plan covers. If the plan wants prior authorization, it wants to agree to the request before paying.
For Medicare’s drug benefit as checked November 3, 2026, an accepted use such as treating diabetes can allow a coverage request. A plan can still decline it under its rules.
Source: Centers for Medicare & Medicaid Services, coverage policy discussion
Ask the plan to explain the reason for its answer in ordinary words. Keep any reference number and the written decision. If the office is helping with the request, ask who is handling it and when you can expect to hear back.
Ordinary Medicare coverage and a temporary program
The regular drug benefit
The Medicare drug benefit is called Part D. Under the law checked November 3, 2026, Part D leaves medicines out when their use is weight loss.
A different medically accepted use can allow coverage consideration, subject to the plan’s rules.
Ask the plan which route applies to your prescription rather than assuming the answer from the drug’s familiar name.
The separate Bridge
CMS is the federal agency that runs Medicare. In the September 26, 2026 CMS record, eligible Part D members owe a $50 monthly copay through the GLP-1 Bridge. This temporary Medicare program provides access to certain medicines used for weight loss. The program lasts through December 31, 2027, having begun July 1, 2026.
The hormone called GLP-1 has roles in blood sugar control and appetite. Medicines that mimic it are often grouped under its name.
The Bridge operates outside the normal Part D payment system rather than changing the weight-loss exclusion.
Source: CMS, Medicare GLP-1 Bridge
The advertised copay has conditions
The Bridge requires age 18 or above, so an older adult meets the age minimum but must still meet the other criteria. BMI means body mass index: it relates a person’s weight to their height. CMS uses the BMI and health conditions from when GLP-1 treatment began:
- With BMI at 35 or more, the weight requirement is met without an added health condition.
- When BMI is at least 30, a qualifying health condition is needed too. The heart-failure option is the type with preserved ejection fraction. The kidney option is chronic kidney disease, with stage 3a as the minimum. The blood-pressure option means readings stay too high despite two medicines: either the bottom number exceeds 90 or the top number exceeds 140.
- For BMI of at least 27, the additional condition can be peripheral artery disease with symptoms, prediabetes, a previous stroke or an earlier heart attack.
The plan requirement can be met by standalone Part D coverage. It can also be met by a coordinated care Medicare Advantage plan with drug benefits. The program requires a prescription and approval in advance, called prior authorization. The medicine must be prescribed with ongoing lifestyle changes, including structured nutrition and physical activity.
The September 26, 2026 Bridge criteria route type 2 diabetes to the ordinary Part D benefit. People with that diagnosis do not qualify for the Bridge.
Besides type 2 diabetes, another excluded condition is moderate to severe obstructive sleep apnea, which involves blocked breathing during sleep. For the liver disease MASH, the exclusion applies only without cirrhosis and with scarring at a moderate or advanced stage. For a prescription aimed at lowering major cardiovascular risk—serious heart or blood-vessel events—the request goes through ordinary Part D. A GLP-1 medicine paid for under Part D at any point during 2026 rules out Bridge use for that same year.
The $50 Bridge copay makes no progress toward Part D’s normal limit on what you pay. You cannot add discount coupons to a Bridge prescription payment.
Source: CMS, Bridge information for prescribers
Source: CMS, Bridge information for Part D plans
Ask the prescriber and plan to check your situation against the linked CMS criteria. The headline amount does not establish that you qualify.
Compare the answer with the cash option
Ask for the amount owed through the plan and, separately, the amount owed outside it. Add the care fee to each route. Check what the quote says about tests, follow-up and medicine so that a bundled offer does not hide an extra charge.
Manufacturer copay cards recorded September 26, 2026 exclude government-program beneficiaries, while manufacturer cash prices may still be available to them outside insurance.
The distinction is between a copay card and a cash offer, rather than a general ban on manufacturer pricing for Medicare members.
If a claim is denied, ask the plan for the reason and its review options. Take that answer back to the clinician, along with the cost you can manage. You can ask about other approaches without agreeing to a different medicine on the spot.